Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can mandatory pretransfusion approval programmes be improved?

T E Hawkins1, J M Carter, P M Hunter

  • 1Haematology Department, Wellington Hospital, New Zealand.

Transfusion Medicine (Oxford, England)
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Some Thoughts on Municipal Milk-Inspection.

The Journal of comparative medicine and veterinary archives·2022
Same author

Tumors.

The Journal of comparative medicine and veterinary archives·2022
Same author

Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Role of sports psychology and sports nutrition in return to play from musculoskeletal injuries in professional soccer: an interdisciplinary approach.

European journal of sport science·2020
Same author

Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.

Parasite immunology·2018
Same journal

Prioritising parameters to minimise blood transfusions for postpartum haemorrhage: A machine learning study using national population data.

Transfusion medicine (Oxford, England)·2026
Same journal

Implementation of BSH 2020 irradiation guidelines for children with DiGeorge syndrome.

Transfusion medicine (Oxford, England)·2026
Same journal

FAIRly deferred: Low impact of the individualised risk assessment policy on blood donor deferrals in England.

Transfusion medicine (Oxford, England)·2026
Same journal

Functional validation of a modified platelet desialylation test for immune and hereditary thrombocytopenias.

Transfusion medicine (Oxford, England)·2026
Same journal

BSH guideline for the estimation of fetomaternal haemorrhage.

Transfusion medicine (Oxford, England)·2026
Same journal

Can a pop-up stop a TACO? A best practice advisory alert as a clinical decision support tool to mitigate the occurrence of transfusion-associated circulatory overload.

Transfusion medicine (Oxford, England)·2026
See all related articles

Implementing mandatory haematologist approval for blood components reduced fresh frozen plasma (FFP) use. However, concurrent audits revealed ongoing inappropriate prescribing, highlighting the need for continuous quality improvement in transfusion practices.

Area of Science:

  • Transfusion Medicine
  • Clinical Pathology
  • Healthcare Quality Improvement

Background:

  • Inappropriate blood component prescribing impacts patient safety and resource utilization.
  • Mandatory pretransfusion approval aims to enhance the appropriateness of non-red-cell component transfusions.

Purpose of the Study:

  • To evaluate the impact of a mandatory haematologist pretransfusion approval program on blood component utilization.
  • To assess the ongoing appropriateness of blood component prescribing despite the implemented approval policy.

Main Methods:

  • Institution of a mandatory haematologist pretransfusion approval program for non-red-cell components.
  • Concurrent audit of fresh frozen plasma (FFP), cryoprecipitate, and platelet usage against preset criteria over a 3-month period.

Related Experiment Videos

Main Results:

  • A 33% reduction in fresh frozen plasma (FFP) units transfused was observed post-implementation.
  • Platelet transfusions increased, with overall utilization of platelets and FFP becoming the lowest among comparable regions.
  • A concurrent audit revealed 33% of FFP and 30% of cryoprecipitate units were inappropriately transfused despite prior approval.

Conclusions:

  • Mandatory pretransfusion approval improves hospital transfusion practices but requires concurrent auditing for sustained effectiveness.
  • Continuous auditing is essential to identify and rectify persistent inappropriate blood component prescribing.
  • Standardized agreement on blood component indications among haematologists is crucial before implementing approval programs for optimal patient management.